Literature DB >> 12675864

The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy.

Yuansheng Xie1, Shinichi Nishi, Mitsuhiro Ueno, Naofumi Imai, Minoru Sakatsume, Ichiei Narita, Yasushi Suzuki, Kouhei Akazawa, Hisaki Shimada, Masaaki Arakawa, Fumitake Gejyo.   

Abstract

BACKGROUND: Little information has been available until now about the clinical efficacy of tonsillectomy on long-term renal survival of patients with idiopathic immunoglobulin A nephropathy (IgAN).
METHODS: To investigate the effect of tonsillectomy on long-term renal survival, we reviewed the clinical course of 118 patients with idiopathic biopsy-diagnosed IgAN from 1973 to 1980. Of those, 48 patients received tonsillectomy and 70 patients did not. The starting point of observation was defined as the time of the diagnostic renal biopsy, and the end point as when requiring the first dialysis. Up to 2001, the mean observation time was 192.9 +/- 74.8 months (48-326 months). Renal survival and impact of covariates were evaluated by Kaplan-Meier analysis and Cox proportional hazards regression model.
RESULTS: Age, gender, amount of urinary protein excretion, serum creatinine, serum IgA, blood pressure, and histopathologic findings at the time of renal biopsy and treatments during the observation period were not significantly different between patients with and without tonsillectomy. Five (10.4%) of the patients with tonsillectomy and 18 (25.7%) of the patients without tonsillectomy finally required dialysis therapy (chi-square test, P = 0.0393). By Kaplan-Meier analysis, renal survival rates were 89.6% and 63.7% at 240 months in the patients with and without tonsillectomy, respectively, and were significantly different (log-rank test, P = 0.0329). In the multivariate Cox regression model, tonsillectomy (hazard ratio, 0.22; 95% CI, 0.06 to 0.76; P = 0.0164) had a significant effect on renal outcome.
CONCLUSION: These results indicate that tonsillectomy has a favorable effect on long-term renal survival in patients with IgAN.

Entities:  

Mesh:

Year:  2003        PMID: 12675864     DOI: 10.1046/j.1523-1755.2003.00935.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  48 in total

1.  Selective expansion of T cell receptor (TCR) V beta 6 in tonsillar and peripheral blood T cells and its induction by in vitro stimulation with Haemophilus parainfluenzae in patients with IgA nephropathy.

Authors:  H Nozawa; M Takahara; T Yoshizaki; T Goto; N Bandoh; Y Harabuchi
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

2.  Tonsillectomy as part of the treatment for IgA nephropathy: cooperation between nephrologists and otolaryngologists.

Authors:  Satoru Kodama; Masashi Suzuki
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

3.  Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy.

Authors:  Miho Tatematsu; Yoshinari Yasuda; Yoshiki Morita; Izumi Sakamoto; Kei Kurata; Tomohiko Naruse; Rhohei Yamamoto; Naotake Tsuboi; Waichi Sato; Enyu Imai; Seiichi Matsuo; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2012-05-23       Impact factor: 2.801

4.  A case of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome complicated by IgA nephropathy with nephrotic syndrome.

Authors:  Katsuhiko Morimoto; Kimihiko Nakatani; Osamu Asai; Kuniko Mondori; Kiyonori Tomiwa; Takamitsu Mondori; Yoshiyuki Nakagawa; Masayuki Iwano; Hideo Shiiki
Journal:  CEN Case Rep       Date:  2015-05-27

5.  Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy.

Authors:  Yukihiko Kawasaki; Kei Takano; Kazuhide Suyama; Masato Isome; Hideki Suzuki; Hiroko Sakuma; Tomoo Fujiki; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

Review 6.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

7.  Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy.

Authors:  Naoto Miura; Hirokazu Imai; Shogo Kikuchi; Shogo Hayashi; Masayuki Endoh; Tetsuya Kawamura; Yasuhiko Tomino; Kumiko Moriwaki; Hideyasu Kiyomoto; Kentaro Kohagura; Eiko Nakazawa; Eiji Kusano; Toshio Mochizuki; Shinsuke Nomura; Tamaki Sasaki; Naoki Kashihara; Jun Soma; Tadashi Tomo; Iwao Nakabayashi; Masaharu Yoshida; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

8.  Renal outcome after tonsillectomy plus corticosteroid pulse therapy in patients with immunoglobulin A nephropathy: results of a multicenter cohort study.

Authors:  Junichi Hoshino; Takayuki Fujii; Joichi Usui; Takeshi Fujii; Kenichi Ohashi; Kenmei Takaichi; Satoshi Suzuki; Yoshifumi Ubara; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2015-11-14       Impact factor: 2.801

Review 9.  [IgA nephropathy: frequent, but rarely diagnosed].

Authors:  J Floege; H-J Gröne
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

10.  A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.

Authors:  Masashi Goto; Kenji Wakai; Takashi Kawamura; Masahiko Ando; Masayuki Endoh; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2009-06-10       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.